Welcome to the Metastatic Breast Cancer: Updates in Clinical Practice registration website!
Join us for one of these educational events and earn up to 3.0 credit hours of continuing education.
All meetings take place from 8:30 am – 12:00 pm and include breakfast and lunch.
There are no fees for participation.
| Saturday, October 15, 2011 Houston, Texas Hilton Houston Plaza/Medical Center 6633 Travis Street Houston, TX 77030  |
Saturday, October 22, 2011 Los Angeles, California Hotel Palomar Los Angeles 10740 Wilshire Blvd. at Selby Ave. Los Angeles, CA 90024  |
Saturday, November 12, 2011 Chicago, Illinois Elysian Hotel Chicago 11 East Walton Street Chicago, IL 60611  |
Supported by an educational grant from Genentech, Inc.
Program Overview
The faculty team, comprised of national thought leaders, will address the latest clinical data emerging from recent meetings in the area of breast cancer, including appropriate test practices to determine HER2 and hormone receptor status, current treatment guidelines for locally recurrent and metastatic breast cancer (MBC), as well as options for treatment-resistant MBC in recurrent breast cancer patients.
Target Audience
This activity is designed for physicians, pharmacists, physician assistants, nurses, and nurse practitioners who have an interest in enhancing their clinical skills in the management of metastatic breast cancer.
Learning Objectives
Upon completion of this educational activity, participants should be able to:
- Explain the necessity of HER2 and hormone receptor status in choosing initial treatment for locally recurrent and/or MBC, and explain the considerations in choosing among different assays and laboratories
- List and classify the most promising current as well as new and emerging therapeutic options for ER+, HER2+ and triple-negative locally recurrent and/or MBC patients, including special considerations based on individual patient risk factors
- Summarize the latest evidence-based guidelines regarding management of locally recurrent and/or MBC with attention to optimal sequencing and combination of agents
- Develop treatment plans for locally recurrent and/or MBC patients tailored according to hormone and HER2 receptor status and previous response to treatment
Agenda
| 8:30 am – 8:55 am | Breakfast and Registration |
| 8:55 am – 9:00 am | Introductions/Program Overview |
| 9:00 am – 9:55 am | Considerations in the Management of ER/PR+ Metastatic Breast Cancer/Q&A |
| 9:55 am – 10:50 am | Considerations in the Management of HER2+ Metastatic Breast Cancer/Q&A |
| 10:50 am – 11:00 am | Break |
| 11:00 am – 11:55 am | Considerations in the Management of Triple-Negative and Hormone-Refractory Metastatic Breast Cancer/Q&A |
| 11:55 am – 12:00 pm | Moderator Conclusions and Closing Remarks |
| 12:00 pm – 12:30 pm | Lunch and Adjournment |
If you have any questions regarding this activity, please contact MediCom at 800-408-4242, ext. 128 or email info@medicaled.com
Accreditation
CME CREDIT
Accreditation Statement: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this live educational activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CPE CREDIT
MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is acceptable for 3.0 contact hours of Continuing Education Credit.
Universal Activity Number: 827-0000-11-264-L01-P. Knowledge-based CPE activity.
In order for CPE Monitor to authenticate credit, pharmacists/technicians must provide their ID and date of birth (in MMDD format) when registering for a CPE program.
NURSING CREDIT
Accreditation Statement: MediCom Worldwide, Inc., 101 Washington Street, Morrisville, PA 19067 is approved by the California Board of Registered Nursing, Provider Number CEP11380. MediCom designates this CNE activity for 3.0 contact hours. Program Number: 11-264-253
For information on applicability and acceptance of continuing nursing education credit for this activity, please consult your professional licensing board.
Disclosure
In accordance with the Accreditation Council for Continuing Medical Education (ACCME), ACPE and California Board of Nursing, MediCom Worldwide, Inc. requires that all program planners, faculty, and providers who are in a position to control the content of a CE activity are required to disclose any relevant financial relationships they may have or have had within the last 12 months with the commercial supporter or the manufacturer(s) of any commercial device(s) discussed in this educational activity.
Conflict of Interest Resolution
MediCom Worldwide, Inc. has established policies in place that will identify and resolve conflicts of interest prior to this educational activity. When individuals in a position to control content have reported financial relationships with one or more commercial interests, MediCom Worldwide, Inc. works with them to resolve such conflicts to ensure that the content presented is free of commercial bias.
Americans with Disabilities Act/Special Needs
MediCom Worldwide, Inc. is committed to equality of educational opportunity and does not discriminate against applicants, students, or employees on the basis of race, color, religion, sex, national origin, age, disability, veterans status, or sexual orientation. If you require reasonable accommodations for a disability in order to participate fully in this continuing education activity, please call 800-408-4242 no later than 14 days prior to the activity.
There are no fees for participating in this activity. All participants must complete the Activity Evaluation Form. Participants must receive a minimum score of 70% on the self-assessment portion of the form to qualify for CE credit.
Certificates will be mailed 4 to 6 weeks following receipt of a completed, qualified form. Pharmacist credit will be uploaded to CPE Monitor 4 to 6 weeks following receipt of a completed, qualified form.
©2011 MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067. 1-800-408-4242
No portion of this material may be copied or duplicated without the expressed permission of MediCom Worldwide, Inc.